Literature DB >> 7518770

Effects of NMDA- and AMPA-receptor antagonists on different forms of epileptiform activity in rat temporal cortex slices.

C L Zhang1, T Gloveli, U Heinemann.   

Abstract

Lowering extracellular magnesium induces different patterns of epileptiform activity in rat hippocampus and entorhinal cortex. Short recurrent epileptiform discharges in the hippocampus are stable over time, whereas seizure-like events (SLEs) in the entorhinal cortex, the subiculum, and the neighboring neocortex develop into late recurrent discharges which are not blocked by clinically employed antiepileptic drugs. We tested the sensitivity of the different epileptiform discharge patterns to N-methyl-D-aspartate (NMDA)- and non-NMDA-receptor antagonists. As NMDA-receptor antagonist we used dextrorphan, ketamine, and 2-aminophosphonovalerate (2APV); as alpha-amino-3-hydroxy-5-methyl-4-isoxazole-propionic acid (AMPA)-receptor antagonist we employed the quinoxaline derivative glutamate 6-cyano-7-nitroquinoxaline-2,3-dione (CNQX). The findings show that the different patterns of epileptiform activity, including the late recurrent discharges, are sensitive to all NMDA-receptor antagonists. However, when dextrorphan was employed to suppress seizure-like events, later recurrent discharges did not develop during the remaining time course of the experiment. CNQX reversibly suppressed recurrent discharges in the hippocampus and SLEs in the entorhinal cortex. However, late recurrent discharges become insensitive to CNQX, even at a high concentration of 60 microns. This finding suggests a prominent role for NMDA receptors in the generation of late recurrent discharges.

Entities:  

Mesh:

Substances:

Year:  1994        PMID: 7518770     DOI: 10.1111/j.1528-1157.1994.tb05973.x

Source DB:  PubMed          Journal:  Epilepsia        ISSN: 0013-9580            Impact factor:   5.864


  6 in total

1.  Recovery of network-driven glutamatergic activity in rat hippocampal neurons during chronic glutamate receptor blockade.

Authors:  Eric Leininger; Andrei B Belousov
Journal:  Brain Res       Date:  2008-11-25       Impact factor: 3.252

2.  Effects of gamma-aminobutyric acid (GABA) agonists and GABA uptake inhibitors on pharmacosensitive and pharmacoresistant epileptiform activity in vitro.

Authors:  M Pfeiffer; A Draguhn; H Meierkord; U Heinemann
Journal:  Br J Pharmacol       Date:  1996-10       Impact factor: 8.739

3.  Effects of methysticin on three different models of seizure like events studied in rat hippocampal and entorhinal cortex slices.

Authors:  D Schmitz; C L Zhang; S S Chatterjee; U Heinemann
Journal:  Naunyn Schmiedebergs Arch Pharmacol       Date:  1995-04       Impact factor: 3.000

4.  Recurrent epileptiform discharges in the medial entorhinal cortex of kainate-treated rats are differentially sensitive to antiseizure drugs.

Authors:  Peter J West; Gerald W Saunders; Peggy Billingsley; Misty D Smith; H Steve White; Cameron S Metcalf; Karen S Wilcox
Journal:  Epilepsia       Date:  2018-10-17       Impact factor: 5.864

Review 5.  Comparison of the effects of serotonin in the hippocampus and the entorhinal cortex.

Authors:  D Schmitz; T Gloveli; R M Empson; U Heinemann
Journal:  Mol Neurobiol       Date:  1998       Impact factor: 5.590

Review 6.  The piriform, perirhinal, and entorhinal cortex in seizure generation.

Authors:  Marta S Vismer; Patrick A Forcelli; Mark D Skopin; Karen Gale; Mohamad Z Koubeissi
Journal:  Front Neural Circuits       Date:  2015-05-29       Impact factor: 3.492

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.